Abstract:Debiao Xiang, 1– 3 Lili Zhou, 4 Rui Yang, 1, 4 Fang Yuan, 1– 3 Yilin Xu, 4 Yuan Yang, 1, 4 Yong Qiao, 1– 3 Xin Li 1– 3 1 Department of Pharmacy, The Third Hospital of Changsha, Changsha, Hunan Province, People's Republic of China; 2 Hunan Provincial Key Laboratory of Anti-Resistance Microbial Drugs, Changsha, Hunan Province, People's Republic of China; 3 The Clinical Application Research Institute of Antibiotics in Changsha, Changsha, Hunan Province, People's Republic of China; 4 College of Pharmacy, Hunan University of Chinese Medicine, Changsha, Hunan Province, People's Republic of China Correspondence: Xin Li, 176 Laodong West Road, Tianxin District, Changsha, Hunan Province, People's Republic of China, Tel +86 0731-85171320, Email Currently, cancer remains one of the most significant threats to human health. Treatment of most cancers remains challenging, despite the implementation of diverse therapies in clinical practice. In recent years, research on the mechanism of ferroptosis has presented novel perspectives for cancer treatment. Ferroptosis is a regulated cell death process caused by lipid peroxidation of membrane unsaturated fatty acids catalyzed by iron ions. The rapid development of bio-nanotechnology has generated considerable interest in exploiting iron-induced cell death as a new therapeutic target against cancer. This article provides a comprehensive overview of recent advancements at the intersection of iron-induced cell death and bionanotechnology. In this respect, the mechanism of iron-induced cell death and its relation to cancer are summarized. Furthermore, the feasibility of a nano-drug delivery system based on iron-induced cell death for cancer treatment is introduced and analyzed. Secondly, strategies for inducing iron-induced cell death using nanodrug delivery technology are discussed, including promoting Fenton reactions, inhibiting glutathione peroxidase 4, reducing low glutathione levels, and inhibiting system Xc − . Additionally, the article explores the potential of combined treatment strategies involving iron-induced cell death and bionanotechnology. Finally, the application prospects and challenges of iron-induced nanoagents for cancer treatment are discussed. Keywords: cancers, ferroptosis, nano-drug delivery system, target Over the past decade, various malignant tumor treatment methods have been applied in the clinic, including traditional treatment strategies such as surgery, chemotherapy, radiotherapy, and emerging immunotherapy. 1 However, due to the inherent limitations of conventional treatment approaches and the heterogeneity of tumors, their clinical efficacy remains dismal. 2,3 Although immunotherapy has become a promising cancer treatment in recent years, its narrow anti-tumor spectrum, potential toxicity, and autoimmune suppression have greatly limited its clinical application. 4,5 Additionally, drug delivery barriers within solid tumors account for the poor efficacy of tumor immunotherapy. 6,7 Therefore, in the face of the serious threat to human health posed by malignant tumors, there is an urgent need for a safer and more effective treatment approach. In recent years, emerging biomedical developments and technological innovations have provided more possibilities for effectively treating cancer. 8 An increasing body of literature suggests that inducing iron death in tumor cells represents a potential new anti-tumor strategy. 9,10 Iron is one of the essential elements of the human body. It exists in the form of hemoglobin, myoglobin, and other compounds, and the rest is stored as ferritin in the liver, spleen, and bone marrow. 11,12 Iron is reportedly involved in metabolic processes and various life activities, including oxygen transport, cell respiration, electron transfer, DNA synthesis, and immune regulation. 13,14 The abnormal metabolism of iron leads to many physiological disorders. In this regard, the presence of Fe 2+ in cells greatly accelerates the lipid peroxidation of saturated fat. 15 During mitochondrial oxidative phosphorylation, where iron is involved, cells generate both adenosine triphosphate (ATP) and reactive oxygen species (ROS). 16 If the production of ROS surpasses the cellular antioxidant capacity, it can trigger oxidative stress reactions. 17 Consequently, macromolecules like proteins, nucleic acids, and lipids may suffer damage, ultimately leading to cell impairment or death. 18–20 This novel form of regulated cell death is called ferroptosis. In recent years, research on ferroptosis has increased exponentially. 21 It is widely thought that the i -Abstract Truncated-

A Specific Targeted Enhanced Nanotherapy Strategy for Inducing Ferroptosis by Regulating the Iron Pool Levels in Tumor Cells

Targeting Ferroptosis in Breast Cancer

Targeting Ferroptosis for Cancer Therapy: Exploring Novel Strategies from Its Mechanisms and Role in Cancers

Advances in Ferroptosis-Inducing Agents by Targeted Delivery System in Cancer Therapy

Targeting Ferroptosis for Cancer Therapy: Iron Metabolism and Anticancer Immunity.

Nanomedicine-mediated ferroptosis targeting strategies for synergistic cancer therapy.

Targeting ferroptosis-based cancer therapy using nanomaterials: strategies and applications

Cell-Specific Metabolic Reprogramming of Tumors for Bioactivatable Ferroptosis Therapy.

Ferroptosis-Inducing Nanomedicine for Cancer Therapy

Emerging Therapeutic Approaches Targeting Ferroptosis in Cancer: Focus on Immunotherapy and Nanotechnology

Ferroptosis Nanomedicine: Clinical Challenges and Opportunities for Modulating Tumor Metabolic and Immunological Landscape

The Molecular Mechanisms of Regulating Oxidative Stress-Induced Ferroptosis and Therapeutic Strategy in Tumors

Emerging mechanisms and targeted therapy of ferroptosis in cancer

Nanotechnology-integrated Ferroptosis Inducers: A Sharp Sword against Tumor Drug Resistance

Highly selective and effective ferroptosis liposomal nanodrugs for synergistic antitumor therapy

Insights Into Ferroptosis, a Novel Target for the Therapy of Cancer

Boosting The Ferroptotic Antitumor Efficacy Via Site-Specific Amplification Of Tailored Lipid Peroxidation

A Supramolecular Self-Assembled Nanoprodrug for Enhanced Ferroptosis Therapy

Ferroptosis in Cancer Treatment: Another Way to Rome

Nanomaterial-induced ferroptosis for cancer specific therapy

Advances in ferroptosis of cancer therapy